10-119651741-GC-GCC
Variant summary
Our verdict is Pathogenic. The variant received 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_004281.4(BAG3):c.72dupC(p.Gly25ArgfsTer33) variant causes a frameshift change. The variant allele was found at a frequency of 0.00000553 in 1,447,244 control chromosomes in the GnomAD database, with no homozygous occurrence. There is a variant allele frequency bias in the population database for this variant (GnomAdExome4), which may indicate mosaicism or somatic mutations in the reference population data. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. G25G) has been classified as Likely benign.
Frequency
Consequence
NM_004281.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- dilated cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- dilated cardiomyopathy 1HHInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- myofibrillar myopathyInheritance: AD Classification: DEFINITIVE Submitted by: G2P, ClinGen
- myofibrillar myopathy 6Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Charcot-Marie-tooth disease, axonal, type 2JJInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
- distal hereditary motor neuropathyInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 16 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| BAG3 | ENST00000369085.8 | c.72dupC | p.Gly25ArgfsTer33 | frameshift_variant | Exon 1 of 4 | 1 | NM_004281.4 | ENSP00000358081.4 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.0000169 AC: 4AN: 236006 AF XY: 0.0000233 show subpopulations
GnomAD4 exome AF: 0.00000553 AC: 8AN: 1447244Hom.: 0 Cov.: 31 AF XY: 0.00000556 AC XY: 4AN XY: 720004 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Reported in association with DCM, though patient-specific clinical details are lacking (Domnguez et al., 2018); This variant is associated with the following publications: (PMID: 30442290) -
Myofibrillar myopathy 6;C3151293:Dilated cardiomyopathy 1HH Pathogenic:1
This sequence change creates a premature translational stop signal (p.Gly25Argfs*33) in the BAG3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in BAG3 are known to be pathogenic (PMID: 21353195, 25008357). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individual(s) with BAG3-related conditions (PMID: 30442290). ClinVar contains an entry for this variant (Variation ID: 966196). For these reasons, this variant has been classified as Pathogenic. -
Cardiovascular phenotype Pathogenic:1
The c.72dupC pathogenic mutation, located in coding exon 1 of the BAG3 gene, results from a duplication of C at nucleotide position 72, causing a translational frameshift with a predicted alternate stop codon (p.G25Rfs*33). This variant has been detected in individuals from a dilated cardiomyopathy cohort (Domínguez F et al. J Am Coll Cardiol, 2018 11;72:2471-2481). Loss of function alterations have been reported in numerous cases of familial dilated cardiomyopathy, including many families with strong segregation with disease (Norton N et al. Am J Hum Genet. 2011;88(3):273-82; Villard E et al. Eur Heart J. 2011;32(9):1065-76; Chami N et al. Can J Cardiol. 2014;30(12):1655-61; Feldman AM et al. J Cell Physiol. 2014;229(11):1697-702; Franaszczyk M et al. J Transl Med. 2014;12:192; van Spaendonck-Zwarts KY et al. Eur Heart J. 2014;35(32):2165-73). In addition, in Norton et al. 2011, BAG3 knockdown in a zebrafish model showed heart failure with decreased fractional shortening and pericardial effusion. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at